Siemens Receives FDA 510(K) Clearance for Next Generation Radiation Therapy Solution
24 January 2008 - 5:14AM
PR Newswire (US)
ARTISTE Solution Offers Unprecedented Flexibility for Tailoring
Treatments to Individual Patient Needs CONCORD, Calif., Jan. 23
/PRNewswire/ -- Siemens Medical Solutions
(http://www.usa.siemens.com/medical) announced it has received FDA
510(k) marketing clearance for the sale and distribution of its
most recent innovation in radiation therapy technology, the
ARTISTE(TM) Solution. (Logo:
http://www.newscom.com/cgi-bin/prnh/20070904/SIEMENSLOGO ) (Photo:
http://www.newscom.com/cgi-bin/prnh/20080123/NYW124 ) Developed by
Siemens' Oncology Care Systems, the ARTISTE Solution is a linear
accelerator engineered specifically for Adaptive Radiation Therapy
(ART). Unique in design, ARTISTE is an integrated imaging and
workflow solution that provides a comprehensive portfolio of
image-guided and advanced treatment delivery protocols. This new
radiation therapy solution offers clinicians multiple imaging
modalities. From Megavoltage (MV) to gold-standard, in-room CT
imaging, clinicians can select the optimal imaging application for
their treatment approach. Siemens' MVision(TM) Cone Beam Imaging
Package delivers outstanding soft-tissue resolution, especially in
challenging cases, such as imaging prostheses and with large
patients. The CTVision(TM) CT-on-rails System provides in-room,
diagnostic quality imaging; thus opening up opportunities to
implement benchmark concepts, such as daily re-planning. "Patient
anatomy and tumor size and shape change during the course of
treatment, often making it difficult to maximize dosage to target
tissue while sparing healthy tissue," said Holger Schmidt,
president of Siemens Medical Solutions, Oncology Care Systems
Division. "ARTISTE provides both fast, powerful 3D MV imaging and
CT high-contrast imaging to help monitor daily changes and enable
precise radiation treatment delivery. Along with the improved tumor
conformity, high-leaf speed, and low leakage of the new 160 MLC(TM)
Multileaf Collimator, ARTISTE empowers clinicians -. offering them
the flexibility and assurance they need to deliver optimal care."
ARTISTE's design incorporates an array of proven components that
reinforces clinicians' confidence in adapting protocols for each
patient. For precise patient positioning, the 550 TxT(TM) Treatment
Table meets the growing demand for accuracy and stability, while
providing the mechanical strength to accommodate a patient weight
capacity of up to 550 lbs (250 kg). The ARTISTE Solution is further
enhanced by Siemens' comprehensive software solution, syngo(R)
Suite for Oncology, a workflow platform providing scalable
workspaces that enable clinical team members to access data,
patient information, and images as needed. "Worldwide demographics
continue to change and healthcare demands are on the rise. Higher
cancer rates and the increasing need for radiation therapy
solutions pose many questions, and Siemens has answers," said
Schmidt. "With innovations like ARTISTE, we provide the reliability
and options that support optimized radiation therapy and simplified
clinical workflow, as well as a clear upgrade path for the
incorporation of changes in clinical scope and future treatment
advances." Siemens is one of the world's largest suppliers to the
healthcare industry. The company is a renowned medical solutions
provider with core competence and innovative strength in diagnostic
and therapeutic technologies as well as in knowledge engineering,
including information technology and system integration. With its
laboratory diagnostics acquisitions, Siemens will be the first
fully integrated diagnostics company, bringing together imaging and
lab diagnostics, therapy, and healthcare information technology
solutions, supplemented by consulting and support services. The
company delivers solutions across the entire continuum of care --
from prevention and early detection, to diagnosis, therapy and
care. Siemens Healthcare employs more than 49,000 people worldwide
and operates in 130 countries. According to IFRS, in the fiscal
year 2007 (Sept. 30), Siemens Medical Solutions reported sales of
euro 9.85 billion, orders of euro 10.27 billion, and group profit
of euro 1.32 billion (preliminary figures, unaudited). Further
information can be found by visiting
http://www.siemens.com/medical.
http://www.newscom.com/cgi-bin/prnh/20070904/SIEMENSLOGO
http://www.newscom.com/cgi-bin/prnh/20080123/NYW124
http://photoarchive.ap.org/ DATASOURCE: Siemens Medical Solutions
CONTACT: Thomas Schaffner, Siemens Medical Solutions,
+1-610-448-1477, Web site: http://www.usa.siemens.com/medical
Copyright